ScoreWhy is Cytek Biosciences, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -20.85% over the last 5 years
2
With a fall in Net Sales of -2.18%, the company declared Very Negative results in Jun 25
- NET PROFIT(9M) At USD -16.59 MM has Grown at -49.46%
- INTEREST(9M) At USD 2.07 MM has Grown at 113.83%
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -13.00%, its profits have fallen by -78.1%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -13.00% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Cytek Biosciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Cytek Biosciences, Inc.
-22.45%
-0.04
71.03%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-20.85%
EBIT Growth (5y)
13.50%
EBIT to Interest (avg)
-4.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.65
Sales to Capital Employed (avg)
0.46
Tax Ratio
41.14%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
70.56%
ROCE (avg)
12.81%
ROE (avg)
0.28%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.15
EV to EBIT
-6.91
EV to EBITDA
-11.49
EV to Capital Employed
1.42
EV to Sales
0.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-20.58%
ROE (Latest)
-5.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 1.8 times
-10What is not working for the Company
NET PROFIT(9M)
At USD -16.59 MM has Grown at -49.46%
INTEREST(9M)
At USD 2.07 MM has Grown at 113.83%
Here's what is working for Cytek Biosciences, Inc.
Inventory Turnover Ratio
Highest at 1.8 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Depreciation
Highest at USD 2.89 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Cytek Biosciences, Inc.
Net Profit
At USD -16.59 MM has Grown at -49.46%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 2.07 MM has Grown at 113.83%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
